HBW Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
1,822
+585
+47% +$598K 0.2% 109
2026
Q1
$1.14M Sell
1,237
-92
-7% -$93.3K 0.12% 180
2025
Q4
$1.43M Sell
1,329
-432
-25% -$413K 0.16% 137
2025
Q3
$1.34M Sell
1,761
-346
-16% -$257K 0.15% 146
2025
Q2
$1.64M Buy
2,107
+459
+28% +$357K 0.2% 119
2025
Q1
$1.36M Buy
1,648
+23
+1% +$19.1K 0.19% 116
2024
Q4
$1.25M Buy
1,625
+42
+3% +$34.8K 0.13% 114
2024
Q3
$1.4M Buy
1,583
+666
+73% +$599K 0.21% 111
2024
Q2
$830K Buy
917
+265
+41% +$212K 0.14% 145
2024
Q1
$380K Hold
652
0.07% 198
2023
Q4
$380K Sell
652
-183
-22% -$107K 0.07% 198
2023
Q3
$449K Buy
835
+4
+0.5% +$2.06K 0.09% 184
2023
Q2
$390K Sell
831
-185
-18% -$77.6K 0.08% 202
2023
Q1
$349K Buy
1,016
+34
+3% +$11.5K 0.09% 190
2022
Q4
$359K Buy
+982
New +$348K 0.09% 191

Other funds holding LLY

HBW Advisory Services's LLY Position: Q2 2026 in Review

HBW Advisory Services increased its Eli Lilly (LLY) stake by 47% in Q2 2026, buying an estimated $598K and bringing the position to 1,822 shares worth $2.19M. The position accounts for 0.2% of the portfolio, ranked #109.

HBW Advisory Services first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,713 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HBW Advisory Services held 1,822 shares of Eli Lilly worth $2.19M as of Q2 2026.
  • HBW Advisory Services bought 585 Eli Lilly shares in Q2 2026, an estimated $598K.
  • Eli Lilly made up 0.2% of HBW Advisory Services's portfolio in Q2 2026, its #109 holding.
  • HBW Advisory Services first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,713 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.